Table 1 Echocardiographic parameters of the EDTA and control groups.
From: Attenuation of ischemia–reperfusion injury by intracoronary chelating agent administration
EDTA (n = 10) | Control (n = 10) | p value | ||
|---|---|---|---|---|
Day 0 | LVEDD (mm) | 34 ± 3.1 | 33.0 ± 2.9 | 0.6532 |
LVESD (mm) | 22.6 ± 3.2 | 22.9 ± 2.2 | 0.9023 | |
LVEDV (mL) | 40.0 ± 11.2 | 36.8 ± 9.0 | 0.683 | |
LVESV (mL) | 16.2 ± 7.3 | 15.0 ± 5.7 | 0.8061 | |
LV EF (%) | 61.9 ± 10.7 | 59.2 ± 10.7 | 0.5675 | |
Day 28 | LVEDD (mm) | 38.8 ± 3.3 | 43.9 ± 3.7 | 0.0089 |
LVESD (mm) | 27.5 ± 4.0 | 35.2 ± 4.1 | 0.0028 | |
LVEDV (mL) | 52.1 ± 11.4 | 70.2 ± 14.3 | 0.0101 | |
LVESV (mL) | 28.3 ± 7.9 | 46.5 ± 14.3 | 0.0057 | |
LV EF (%) | 45.3 ± 10.3 | 34.4 ± 11.8 | 0.031 | |
Thinning (mm) | 44.2 ± 1.3 | 86.8 ± 10.5 | 0.003 | |
Total length (mm) | 139.0 ± 5.4 | 141.2 ± 14.5 | 0.76 | |
Thinning ratio (%) | 31.8 ± 0.6 | 61.5 ± 5.9 | 0.002 | |
